List of Excipients in API propylthiouracil
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing propylthiouracil
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Par Pharmaceutical Inc | PROPYLTHIOURACIL | propylthiouracil | 67253-651 | CELLULOSE, MICROCRYSTALLINE | |
| Par Pharmaceutical Inc | PROPYLTHIOURACIL | propylthiouracil | 67253-651 | DOCUSATE SODIUM | |
| Par Pharmaceutical Inc | PROPYLTHIOURACIL | propylthiouracil | 67253-651 | MAGNESIUM STEARATE | |
| Par Pharmaceutical Inc | PROPYLTHIOURACIL | propylthiouracil | 67253-651 | SODIUM BENZOATE | |
| Par Pharmaceutical Inc | PROPYLTHIOURACIL | propylthiouracil | 67253-651 | SODIUM GLYCOLATE | |
| Par Pharmaceutical Inc | PROPYLTHIOURACIL | propylthiouracil | 67253-651 | STARCH, CORN | |
| American Health Packaging | PROPYLTHIOURACIL | propylthiouracil | 68084-964 | CELLULOSE, MICROCRYSTALLINE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing propylthiouracil
Detailed excipient profiles for propylthiouracil
Excipient focus: ANHYDROUS LACTOSE
propylthiouracil drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | propylthiouracil | 42254-010 |
| QUAGEN PHARMACEUTICALS LLC | propylthiouracil | 70752-171 |
| Bryant Ranch Prepack | propylthiouracil | 72162-2072 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM STEARATE
propylthiouracil drug variants containing CALCIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | propylthiouracil | 62135-606 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing CALCIUM STEARATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
propylthiouracil drug variants containing CELLULOSE, MICROCRYSTALLINE
propylthiouracil drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | propylthiouracil | 0228-2348 |
| Teva Pharmaceuticals Inc | propylthiouracil | 0480-9242 |
| NCS HealthCare of KY Inc dba Vangard Labs | propylthiouracil | 0615-7583 |
| Chartwell RX LLC | propylthiouracil | 62135-606 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
propylthiouracil drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | propylthiouracil | 0615-7583 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: DOCUSATE SODIUM
propylthiouracil drug variants containing DOCUSATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | propylthiouracil | 67253-651 |
| American Health Packaging | propylthiouracil | 68084-964 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing DOCUSATE SODIUM
Excipient focus: LACTOSE MONOHYDRATE
propylthiouracil drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | propylthiouracil | 0228-2348 |
| Teva Pharmaceuticals Inc | propylthiouracil | 0480-9242 |
| NCS HealthCare of KY Inc dba Vangard Labs | propylthiouracil | 0615-7583 |
| Chartwell RX LLC | propylthiouracil | 62135-606 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
propylthiouracil drug variants containing MAGNESIUM STEARATE
propylthiouracil drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | propylthiouracil | 62135-606 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
propylthiouracil drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | propylthiouracil | 0228-2348 |
| NCS HealthCare of KY Inc dba Vangard Labs | propylthiouracil | 0615-7583 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
propylthiouracil drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | propylthiouracil | 0480-9242 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
propylthiouracil drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | propylthiouracil | 0228-2348 |
| Teva Pharmaceuticals Inc | propylthiouracil | 0480-9242 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
propylthiouracil drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | propylthiouracil | 67253-651 |
| American Health Packaging | propylthiouracil | 68084-964 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM GLYCOLATE
propylthiouracil drug variants containing SODIUM GLYCOLATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | propylthiouracil | 67253-651 |
| American Health Packaging | propylthiouracil | 68084-964 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing SODIUM GLYCOLATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
propylthiouracil drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| QUAGEN PHARMACEUTICALS LLC | propylthiouracil | 70752-171 |
| Bryant Ranch Prepack | propylthiouracil | 72162-2072 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
propylthiouracil drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | propylthiouracil | 33342-314 |
| Rebel Distributors Corp | propylthiouracil | 42254-010 |
| >Company | >Ingredient | >NDC |
propylthiouracil drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
propylthiouracil drug variants containing STARCH, CORN
propylthiouracil drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
